https://www.nature.com/articles/s41598-022-05225-8
https://pubmed.ncbi.nlm.nih.gov/19323941/
https://www.nature.com/articles/s43587- ... ge-history
I'd been excited about therapies related to cyclophilin-A antagonist molecules after having read the third article listed. However, the first two suggest that the jury is still way out on whether cyclophilin-A is relevant to the development of Alzheimer disease. Will be interested to follow this line of investigation.